We have previously shown that the gut-to-brain axis involving taurocholate/FGF15 improved glucose tolerance in multiple models of obesity and diabetes (14), which was dependent on FGFR1 in AGRP-expressing cells (13). Here, FGFR1 is linked to obesity due to melanocortin 4 receptor deficiency.